Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 100,000 CLDX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 100,000 | n/a |
| Jun 9, 2025 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 85,000 | n/a |
| Jun 18, 2024 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 30,000 | $311.4K |
| Jun 17, 2024 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 85,000 | n/a |
| Jun 11, 2024 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 7,500 | $77.8K |
| Jun 3, 2024 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 34,445 | $95.8K |
| Jun 20, 2023 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 80,000 | n/a |
| Jun 17, 2022 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 77,000 | n/a |
| Dec 10, 2021 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 4,000 | $36.1K |
| Nov 3, 2021 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 8,555 | $23.8K |